do people gain weight after stopping tirzepatide Ozempic, Wegovy, Mounjaro: How to Maintain Stopping Tirzepatide: What To Expect

Safety info : GLP-1 medications are used to treat obesity or overweight (with weight-related problems), along with diet and exercise

GLP-1 receptor agonists should not be used in combination with DPP-4 inhibitors (such as sitagliptin), as both act on the incretin system

Unexplained weight loss that is rapid or associated with inability to maintain adequate nutrition should prompt evaluation for medication dose adjustment or nutritional intervention

Others need the full titration to see significant results

These side effects vary from common and mild to rare and serious conditions that may require medical attention

We are gonna find out